Determination of EGFR Status in Gliomas

作者: Angélique Guillaudeau , Karine Durand , Isabelle Pommepuy , Sandrine Robert , Alain Chaunavel

DOI: 10.1097/PAI.0B013E31818DB320

关键词:

摘要: Epidermal growth factor receptor (EGFR) is produced during the molecular pathogenesis of glioma, and new anti-EGFR molecules are available for therapeutics. Consequently, analyses EGFR gene protein frequently used glioma characterization. We compare accuracy usefulness 2 currently techniques histologic classification gliomas. Fluorescent in situ hybridization (FISH) immunohistochemistry (IHC) were to assess amplification abundance a series 35 gliomas, including World Health Organization (WHO) grade I, II, III astrocytomas (AI, AII, AIII), II tumors with oligodendroglial component (OII, OIII) IV glioblastomas (GBs). was found one-third studied. It frequent GB OIII but never AI, AIII, OII tumors. IHC FISH provided similar findings tumor, despite fact that, contrast amplification, overexpressed AIII GB. observed not containing protein: therefore unnecessary when shows no expression. seems be restricted high-grade tumors, WHO astrocytomas,

参考文章(43)
Kenneth D. Aldape, Karla Ballman, Alfred Furth, Jan. C. Buckner, Caterina Giannini, Peter C. Burger, Bernd W. Scheithauer, Robert B. Jenkins, C. David James, Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Journal of Neuropathology and Experimental Neurology. ,vol. 63, pp. 700- 707 ,(2004) , 10.1093/JNEN/63.7.700
Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)
Holly M. Martinson, John H. Sampson, Gary E. Archer, Gregory J. Riggins, Chad A. Glazer, Anita Lal, Henry S. Friedman, Mutant Epidermal Growth Factor Receptor Up-Regulates Molecular Effectors of Tumor Invasion Cancer Research. ,vol. 62, pp. 3335- 3339 ,(2002)
Naoki Shinojima, Kenji Tada, Shoji Shiraishi, Takanori Kamiryo, Masato Kochi, Hideo Nakamura, Keishi Makino, Hideyuki Saya, Hirofumi Hirano, Jun-ichi Kuratsu, Koji Oka, Yasuji Ishimaru, Yukitaka Ushio, None, Prognostic Value of Epidermal Growth Factor Receptor in Patients with Glioblastoma Multiforme Cancer Research. ,vol. 63, pp. 6962- 6970 ,(2003)
P. H. Huang, A. Mukasa, R. Bonavia, R. A. Flynn, Z. E. Brewer, W. K. Cavenee, F. B. Furnari, F. M. White, Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 12867- 12872 ,(2007) , 10.1073/PNAS.0705158104
Federico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni L. Ceresoli, Lynne Bemis, Jerry Haney, Samir Witta, Kathleen Danenberg, Irene Domenichini, Vienna Ludovini, Elisabetta Magrini, Vanesa Gregorc, Claudio Doglioni, Angelo Sidoni, Maurizio Tonato, Wilbur A. Franklin, Lucio Crino, Paul A. Bunn, Marileila Varella-Garcia, Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 97, pp. 643- 655 ,(2005) , 10.1093/JNCI/DJI112
Janet E Dancey, Boris Freidlin, Targeting epidermal growth factor receptor--are we missing the mark? The Lancet. ,vol. 362, pp. 62- 64 ,(2003) , 10.1016/S0140-6736(03)13810-X
Uri Tabori, Shlomit Rienstein, Yaara Dromi, Leonor Leider-Trejo, Shlomo Constantini, Yoav Burstein, Rina Dvir, Ninette Amariglio, Amos Toren, Gideon Rechavi, Shai Izraeli, Ayala Aviram, Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas Journal of Neurosurgery. ,vol. 103, pp. 357- 361 ,(2005) , 10.3171/PED.2005.103.4.0357
Sverre H. Torp, Eirik Helseth, Are Dalen, Geirmund Unsgaard, Epidermal growth factor receptor expression in human gliomas. Cancer Immunology, Immunotherapy. ,vol. 33, pp. 61- 64 ,(1991) , 10.1007/BF01742530